Showing 1911-1920 of 4065 results for "".
Drugs and Sports: New Challenges, New Testing
https://reachmd.com/programs/focus-on-sports-medicine/drugs-and-sports-new-challenges-new-testing/3000/As athletes make gains in size, speed, and agility, so do the tests that ensure those athletes are doing so without the assistance of illegal, performance-enhancing substances. Host Dr. Gary Kohn speaks with Dr. Don Catlin, founder and chief executive officer of Anti-Doping Research, Inc., in Los AnA Young Iraqi Girl’s Long-Term Prognosis After Heart Surgery
https://reachmd.com/programs/clinicians-roundtable/a-young-iraqi-girls-long-term-prognosis-after-heart-surgery/2612/Despite the tremendous conflict in Iraq, there have been many medical miracles. One such story centers around Amenah Al-Bayati, a young Iraqi girl found ill by a United States Marine Corps battalion surgeon, who suspected the girl had a potentially life-threatening heart condition, fixable only by iRedefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
https://reachmd.com/clinical-practice/cardiology/redefining-hf-care-the-role-of-finerenone-in-patients-with-lvef-40/36521/Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%IBD Expert Panel: When is the Right Time to Refer to GI?
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/ibd-expert-panel-when-is-the-right-time-to-refer-to-gi/10085/Dr. Brian McDonough joins Drs. John Betteridge, Thomas Judge, and Philip Stein to discuss the best protocols driving referrals to GI specialists.Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
https://reachmd.com/programs/cme/evidence-at-a-glance-the-totality-of-evidence-impacting-clinical-decision-making-in-patients-with-hfref-without-a-recent-worsening-event/54634/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.ADAPT AF-DES: Antithrombotic Strategies Beyond 12 Months for Patients With AF Treated With Drug-Eluting-Stents
https://reachmd.com/clinical-practice/cardiology/adapt-af-des-antithrombotic-strategies-beyond-12-months-for-patients-with-af-treated-with-drug-eluting-stents/48694/Will ADAPT AF-DES findings affect your practice? Tune in for antithrombotic management strategies for patients with drug-eluting stents in the setting of AF.Psoriasis Healthcare Barriers: Uncovering Underrepresented Patient Populations
https://reachmd.com/programs/spotlight-psoriasis/psoriasis-healthcare-barriers-uncovering-underrepresented-patient-populations/26298/What healthcare barriers are associated with patients of different ethnicities and backgrounds?Healthcare Cost Containment and Medical Liability Reform
https://reachmd.com/programs/heart-matters/healthcare-cost-containment-and-medical-liability-reform/5513/Defensive medicine and medical liability concerns create a symbiotic relationship that costs everyone in the medical system. Has healthcare reform legislation addressed the medical malpractice issue, and will it do enough to contain healthcare costs? Dr. Mark McClellan, director of the Engelberg CenBeyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
https://reachmd.com/programs/cme/beyond-iop-integrating-ocular-surface-resilience-into-glaucoma-management/49097/Our experts discuss management strategies for individualized ocular surface rehabilitation while maintaining optimal IOP control in patients with glaucoma.Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
https://reachmd.com/programs/project-oncology/preventing-mgussmm-progression-to-multiple-myeloma-with-dietary-interventions/30046/A recent study found that a high-fiber, plant-based diet can delay progression from MGUS and SMM to multiple myeloma. Here are the best foods for patients.